Dopamine Increases CD14(+)CD16(+) Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis
Tina M. Calderon, Dionna W. Williams, Lillie Lopez, Eliseo A. Eugenin, Laura Cheney, Peter J. Gaskill, Mike Veenstra, Kathryn Anastos, Susan Morgello and Joan W. Berman
Journal of neuroimmune pharmacology, v 12(2), pp 353-370
In human immunodeficiency virus-1 (HIV) infected individuals, substance abuse may accelerate the development and/or increase the severity of HIV associated neurocognitive disorders (HAND). It is proposed that CD14(+)CD16(+) monocytes mediate HIV entry into the central nervous system (CNS) and that uninfected and infected CD14(+)CD16(+) monocyte transmigration across the blood brain barrier (BBB) contributes to the establishment and propagation of CNS HIV viral reservoirs and chronic neuroinflammation, important factors in the development of HAND. The effects of substance abuse on the frequency of CD14(+)CD16(+) monocytes in the peripheral circulation and on the entry of these cells into the CNS during HIV neuropathogenesis are not known. PBMC from HIV infected individuals were analyzed by flow cytometry and we demonstrate that the frequency of peripheral blood CD14(+)CD16(+) monocytes in HIV infected substance abusers is increased when compared to those without active substance use. Since drug use elevates extracellular dopamine concentrations in the CNS, we examined the effects of dopamine on CD14(+)CD16(+) monocyte transmigration across our in vitro model of the human BBB. The transmigration of this monocyte subpopulation is increased by dopamine and the dopamine receptor agonist, SKF 38393, implicating D1-like dopamine receptors in the increase in transmigration elicited by this neurotransmitter. Thus, elevated extracellular CNS dopamine may be a novel common mechanism by which active substance use increases uninfected and HIV infected CD14(+)CD16(+) monocyte transmigration across the BBB. The influx of these cells into the CNS may increase viral seeding and neuroinflammation, contributing to the development of HIV associated neurocognitive impairments.
Dopamine Increases CD14(+)CD16(+) Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis
Creators
Tina M. Calderon - Yeshiva University
Dionna W. Williams - Yeshiva University
Lillie Lopez - Yeshiva University
Eliseo A. Eugenin - Rutgers, The State University of New Jersey
Laura Cheney - Yeshiva University
Peter J. Gaskill - Yeshiva University
Mike Veenstra - Yeshiva University
Kathryn Anastos - Yeshiva University
Susan Morgello - Icahn School of Medicine at Mount Sinai
Joan W. Berman - Yeshiva University
Publication Details
Journal of neuroimmune pharmacology, v 12(2), pp 353-370
Publisher
Springer Nature
Number of pages
18
Grant note
DA025567; MH075679; MH090958; DA029476; MH096625; Al035004; Al142590; MH083501; MH100931 / U.S. NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
K99DA044838 / NATIONAL INSTITUTE ON DRUG ABUSE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); European Commission
United Negro College Fund/Merck Graduate Science Dissertation Fellowship
U01AI035004 / NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)
MH080663 / Mount Sinai Institute for NeuroAIDS Disparities Pilot Funds
CFAR/AI051519 / Center for AIDS Research at the Albert Einstein College of Medicine, Montefiore Medical Center
R25MH080663 / NATIONAL INSTITUTE OF MENTAL HEALTH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)
Resource Type
Journal article
Language
English
Academic Unit
College of Medicine; Pharmacology and Physiology; Drexel University
Web of Science ID
WOS:000400077600013
Scopus ID
2-s2.0-85010971976
Other Identifier
991020099141804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
Collaboration types
Domestic collaboration
Web of Science research areas
Neurosciences
Pharmacology & Pharmacy
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services